Revised SPC: Bosulif (bosutinib) tablets

SPC states that, according to population pharmacokinetic analyses, Asians had a lower clearance resulting in increased exposure. Therefore, these patients should be closely monitored for adverse reactions especially in case of dose escalation.

Source:

electronic Medicines compendium